Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Amato

Showing results (331-340 of 353) with videos related to

Pageof 36
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and AzacitidineChiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
Current Pediatric Reviews|September 17, 2016
Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the LiteratureP Ferrara, C Guadagno, A Sbordone, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 23, 2006
Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patientsMichael S McCracken, Jemshed A Khan, Allan E Wulc, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Intermittent exposure to high ambient heat during the second half of gestation in mice causes mild alterations of reproductive endpoints in male embryosKimberly Abt, Ciro M Amato, Abigail Kitakule, et al.
Pharmacotherapy|April 20, 2000
Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical CentersS L Ellis, S J Billups, D C Malone, et al.
Cell Death & Disease|September 7, 2018
BH3 mimetics induce apoptosis independent of DRP-1 in melanomaNabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
The Journal of Investigative Dermatology|December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 MimeticsNabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 27, 2001
Interpreting the findings of the IMPROVE studyB L Carter, D C Malone, S J Billups, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 23, 2004
The smooth surface tunnel porous polyethylene enucleation implantJohn J Woog, Steven C Dresner, Tae Soo Lee, et al.
Oncotarget|November 10, 2016
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatmentsNabanita Mukherjee, Adam Almeida, Katie A Partyka, et al.
Pageof 36

Showing results (331-340 of 353) with videos related to

Sort By:
Pageof 36
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and AzacitidineChiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
Current Pediatric Reviews|September 17, 2016
Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the LiteratureP Ferrara, C Guadagno, A Sbordone, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 23, 2006
Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patientsMichael S McCracken, Jemshed A Khan, Allan E Wulc, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Intermittent exposure to high ambient heat during the second half of gestation in mice causes mild alterations of reproductive endpoints in male embryosKimberly Abt, Ciro M Amato, Abigail Kitakule, et al.
Pharmacotherapy|April 20, 2000
Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical CentersS L Ellis, S J Billups, D C Malone, et al.
Cell Death & Disease|September 7, 2018
BH3 mimetics induce apoptosis independent of DRP-1 in melanomaNabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
The Journal of Investigative Dermatology|December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 MimeticsNabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 27, 2001
Interpreting the findings of the IMPROVE studyB L Carter, D C Malone, S J Billups, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 23, 2004
The smooth surface tunnel porous polyethylene enucleation implantJohn J Woog, Steven C Dresner, Tae Soo Lee, et al.
Oncotarget|November 10, 2016
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatmentsNabanita Mukherjee, Adam Almeida, Katie A Partyka, et al.
Pageof 36